Long term morbidity of neoadjuvant chemoradiation for pancreatic head adenocarcinoma.

Turrini, O; Moutardier, V; Guiramand, J; Viret, F; Giovaninni, M; Delpero, J R

Turrini, O; Moutardier, V; Guiramand, J; Viret, F; Giovaninni, M; Delpero, J R.

Affiliation

Turrini O; Department of Surgical Oncology, Institut Paoli-Calmettes Marseille, 232 Boulevard Ste Marguerite, 13009 Marseille, France. oturrini@yahoo.fr

Eur J Surg Oncol ; 32(1): 77-9, 2006 Feb.

Article in En | MEDLINE | ID: mdl-16305820

Subject(s)

Adenocarcinoma/epidemiology; Pancreatic Neoplasms/epidemiology; Adenocarcinoma/drug therapy; Adenocarcinoma/radiotherapy; Antineoplastic Agents/therapeutic use; Biopsy; Follow-Up Studies; Humans; Morbidity; Neoadjuvant Therapy; Pancreas/diagnostic imaging; Pancreas/pathology; Pancreatic Neoplasms/drug therapy; Pancreatic Neoplasms/radiotherapy; Pancreaticoduodenectomy; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ultrasonography

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Surg Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links